Literature DB >> 15967843

Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice.

Songwen Zhang1, Michael H Picard, Eliza Vasile, Yu Zhu, Robert L Raffai, Karl H Weisgraber, Monty Krieger.   

Abstract

BACKGROUND: Normal chow (low fat)-fed mice deficient in both the HDL receptor SR-BI and apolipoprotein E (SR-BI/apoE dKO) provide a distinctive model of coronary heart disease (CHD). They exhibit early-onset hypercholesterolemia characterized by unesterified cholesterol-rich abnormal lipoproteins (lamellar/vesicular and stacked discoidal particles), occlusive coronary atherosclerosis, spontaneous myocardial infarction, cardiac dysfunction, and premature death ( approximately 6 weeks of age). Mice in which similar features of CHD could be induced with a lipid-rich diet would represent a powerful tool to study CHD. METHODS AND
RESULTS: To generate a diet-inducible model of CHD, we bred SR-BI-deficient (SR-BI KO) mice with hypomorphic apolipoprotein E mice (ApoeR61(h/h)) that express reduced levels of an apoE4-like murine apoE isoform and exhibit diet-induced hypercholesterolemia. When fed a normal chow diet, SR-BI KO/ApoeR61(h/h) mice did not exhibit early-onset atherosclerosis or CHD; the low expression level of the apoE4-like murine apoE was atheroprotective and cardioprotective. However, when fed an atherogenic diet rich in fat, cholesterol, and cholate, they rapidly developed hypercholesterolemia, atherosclerosis, and CHD, a response strikingly similar to that of SR-BI/apoE dKO mice fed a chow diet, and they died 32+/-6 days (50% mortality) after initiation of the high-fat feeding.
CONCLUSIONS: The SR-BI KO/ApoeR61(h/h) mouse is a new model of diet-induced occlusive coronary atherosclerosis and CHD (myocardial infarction, cardiac dysfunction and premature death), allowing control of the age of onset, duration, severity, and possibly regression of disease. Thus, SR-BI KO/ApoeR61(h/h) mice have the potential to contribute to our understanding of CHD and its prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967843     DOI: 10.1161/CIRCULATIONAHA.104.523563

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  51 in total

1.  Study of the development of the mouse thoracic aorta three-dimensional macromolecular structure using two-photon microscopy.

Authors:  Leah M Zadrozny; Edward B Neufeld; Bertrand M Lucotte; Patricia S Connelly; Zu-Xi Yu; Lam Dao; Li-Yueh Hsu; Robert S Balaban
Journal:  J Histochem Cytochem       Date:  2014-10-31       Impact factor: 2.479

Review 2.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

Review 3.  Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?

Authors:  Sven Hermann; Andrea Starsichova; Bianca Waschkau; Michael Kuhlmann; Christian Wenning; Otmar Schober; Michael Schäfers
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

Review 4.  Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

Authors:  Joel S Karliner
Journal:  Biochim Biophys Acta       Date:  2012-06-23

5.  The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.

Authors:  Guanying Wang; Roy Y Kim; Isabella Imhof; Norman Honbo; Fu Sang Luk; Kang Li; Nikit Kumar; Bo-Qing Zhu; Delphine Eberlé; Daniel Ching; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2014-02       Impact factor: 3.105

6.  Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60.

Authors:  Irina N Baranova; Tatyana G Vishnyakova; Alexander V Bocharov; Asada Leelahavanichkul; Roger Kurlander; Zhigang Chen; Ana C P Souza; Peter S T Yuen; Robert A Star; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

7.  Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.

Authors:  Rinku Pal; Qingen Ke; German A Pihan; Ayce Yesilaltay; Marsha L Penman; Li Wang; Chandramohan Chitraju; Peter M Kang; Monty Krieger; Olivier Kocher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

8.  Influence of PDZK1 on lipoprotein metabolism and atherosclerosis.

Authors:  Olivier Kocher; Ayce Yesilaltay; Ching-Hung Shen; Songwen Zhang; Kathleen Daniels; Rinku Pal; Jianzhu Chen; Monty Krieger
Journal:  Biochim Biophys Acta       Date:  2008-03-10

9.  Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.

Authors:  Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

10.  Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.

Authors:  Ayce Yesilaltay; Kathleen Daniels; Rinku Pal; Monty Krieger; Olivier Kocher
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.